Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Drugs In Development, 2022, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is a cancer that starts in ... Read More
-
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Drugs In Development, 2022, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may ... Read More
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030
... testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030. The growth in the U.S. prostate cancer testing market is ... Read More
-
Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032
... global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032. The growth in the ... Read More
-
Colorectal Cancer Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment by ... Read More
-
Prostate Cancer Minimally Invasive Surgery Market (Procedure: Laparoscopic Surgery, Robotic Surgery, Radiation Therapy, Cryosurgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... of Report TMR’s report on the global prostate cancer minimally invasive surgery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-use, By Region, And Segment Forecasts, 2023 - 2030
... The global liver cancer diagnostics market size is expected to reach USD 14.67 billion by 2030, advancing at a CAGR of 6.67% over the forecast period from 2023 to 2030, according to a new report ... Read More
-
Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... 10-year patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment ... Read More
-
2023 Global Forecast for Cancer Gene Therapy (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales (product ... Read More
-
2023 Global Forecast for Breast Cancer Liquid Biopsy Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
-
Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029
... Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029 The cell culture market ... Read More
-
Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography
... Research laboratories) and Geography According to Stratistics MRC, the Global Therapeutic Enzymes Market is accounted for $8467.9 million in 2022 and is expected to reach $18684.8 million by 2028 growing at a CAGR of 14.1% ... Read More
-
The Value of a Modern Data Infrastructure to Accelerate Clinical Diagnosis: The Case of Munich Leukemia Laboratory
... its increasing compute and storage needs as well as support its business innovation plans. The case analyzes key factors that helped MLL to successfully analyze and process next-generation sequencing (NGS) and other diagnostic data in ... Read More
-
Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, Specialty Clinics, Diagnostic Labs, Research and Academic Institutes) & Region - Global Forecast to 2027
... minimal residual disease testing market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0% during the forecast period. Market ... Read More
-
Heart Tumor Market Research Report - Forecast till 2030
... 783.34 million in 2021. A cardiac tumor is an abnormal development of the heart that can be either cancerous (malignant) or non-cancerous. Primary (arising from the heart itself) and secondary cardiac tumors are further classifications ... Read More
-
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage ... Read More
-
KEYTRUDA (pembrolizumab) Drug Insight and Market Forecast – 2032
... picture of the KEYTRUDA (pembrolizumab) for Metastatic Colorectal Cancer in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
The World Market for Liquid Biopsy, 2023
... Market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships. Liquid biopsy is gaining acceptance each year. ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market Insights, Forecast to 2028
... Therapeutics estimated at US$ 15,175.51 million in the year 2022, is projected to reach a revised size of US$ 28,717.44 million by 2028, growing at a CAGR of 11.22% during the forecast period 2022-2028. The ... Read More
-
FASLODEX Drug Insight and Market Forecast – 2032
... of the FASLODEX for ER+ve HER2-ve Breast Cancer in the United States for the study period 2019–2032 is provided in this report along with a detailed description of the FASLODEX for ER+ve HER2-ve Breast Cancer. ... Read More
-
Breast Cancer Diagnostics- Market Insights, Competitive Landscape and Market Forecast–2027
... Others), and by geography is expected to grow at a steady CAGR during the given forecast period owing to increase in the prevalence of breast cancer globally, growing geriatric population, the rising number of government ... Read More
-
Europe Microwave Ablation Market Size, Share & Industry Trends Analysis Report By End-user, By Component (Accessories, Generator, and Power Distribution System), By Application (Oncology, Cardiology, Urology, Orthopedic), By Country and Growth Forecast, 2022 - 2028
... The Europe Microwave Ablation Market would witness market growth of 13.6% CAGR during the forecast period (2022-2028). Microwave ablation technology is expected to gain profitable revenue share in the near future. The use of microwave ... Read More
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
... market is estimated to register a CAGR of 7.1% to reach USD 379 million by 2027 from USD 269 million in 2022. The growing prevalence of cancer and HIV/ AIDS, growing research activities which adopt ... Read More
-
Digital Marketing Trends in Breast Cancer
... followed by Eli Lilly’s Verzenio.com (4.4 million visits). The highest proportion of traffic to branded sites originated from direct sources, followed by organic sources. Pfizer spent the most on digital display advertising (DDA) for Ibrance.com ... Read More
-
Bile Duct Cancer (Cholangiocarcinoma) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... will be more than 71,000 diagnosed prevalent cases of bile duct cancer across 16 pharmaceutical markets. There are seven marketed innovator drugs for the treatment of bile duct cancer, mostly tyrosine kinase inhibitors. R&D activity ... Read More
Research Assistance
